Screening for type 2 diabetes in primary care - Janssen, Paul
32,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Diabetes mellitus has become an important health care problem. Its prevalence is worldwide rapidly increasing. A growing body of evidence suggests that earlier diagnosis and treatment of type 2 diabetes may be beneficial. However, definitive evidence is lacking. The studies presented in this book were conducted within the framework of the international ADDITION study (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care), a multicenter, randomised controlled intervention study in screen-detected type 2 diabetic patients. The ADDITION trial has…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Diabetes mellitus has become an important health
care problem. Its prevalence is worldwide rapidly
increasing. A growing body of evidence suggests that
earlier diagnosis and treatment of type 2 diabetes
may be beneficial. However, definitive evidence is
lacking.
The studies presented in this book were conducted
within the framework of the international ADDITION
study (Anglo-Danish-Dutch Study of Intensive
Treatment in People with Screen-Detected Diabetes in
Primary Care), a multicenter, randomised controlled
intervention study in screen-detected type 2
diabetic patients. The ADDITION trial has been
initiated to evaluate whether screening for
undiagnosed type 2 diabetes is feasible and
subsequent intensified multifactorial treatment is
beneficial.
Autorenporträt
Dr. Paul Janssen is a general practitioner and a researcher at
the Julius Center for Health Sciences and Primary Care,
University Medical Center Utrecht, the Netherlands. In 2007 he
was appointed as staff member at the Department of Guideline
Development and Research Policy of the Dutch College of General
Practitioners.